Drugs in Secondary Stroke Prevention

Overview

Journal Aust Prescr

Date 2021 Jul 2

PMID 34211246

Citations 6

Authors

Chris Tremonti

Mark Thieben

Affiliations

Soon will be listed here.

Abstract

After an ischaemic stroke or transient ischaemic attack, patients have a high risk of having another stroke. Secondary stroke prevention includes antiplatelet therapy, statins and antihypertensives Aspirin, clopidogrel, or a combination of aspirin with dipyridamole are first-line options for secondary stroke prevention in the absence of atrial fibrillation Dual antiplatelet therapy has a benefit in the first three weeks after stroke, but patients should change to a single antiplatelet drug after this time Anticoagulants are indicated if the patient has atrial fibrillation. Avoid combinations of anticoagulants and antiplatelet drugs Patients should be started on statins after an ischaemic stroke. High doses are recommended even if cholesterol concentrations are normal Antihypertensive drugs are recommended for all patients with systolic blood pressures greater than 140/90 mmHg. ACE inhibitors, calcium channel blockers and diuretics are first-line options.

Citing Articles

Evolution of Hospitalisation Due to Stroke in Italy Before and After the Outbreak of the COVID-19 Epidemic: A Population-Based Study Using Administrative Data.

Amodio E, Di Maria G, Lodico M, Genovese D, Muggeo V, Maniscalco L J Clin Med. 2025; 14(2).

PMID: 39860359 PMC: 11765534. DOI: 10.3390/jcm14020353.

Genetic Modifiers of Stroke in Patients with Sickle Cell Disease-A Scoping Review.

Oni M, Brito M, Rotman C, Archer N Int J Mol Sci. 2024; 25(12).

PMID: 38928024 PMC: 11203960. DOI: 10.3390/ijms25126317.

Stem cell therapy as a promising approach for ischemic stroke treatment.

Yaqubi S, Karimian M Curr Res Pharmacol Drug Discov. 2024; 6:100183.

PMID: 38831867 PMC: 11144755. DOI: 10.1016/j.crphar.2024.100183.

The Role of Antiplatelet in the Management of Sickle Cell Disease Patients.

Naramreddy S, Varma A, Taksande A, Meshram R Cureus. 2023; 15(7):e42058.

PMID: 37602132 PMC: 10434724. DOI: 10.7759/cureus.42058.

Medication self-management interventions for persons with stroke: A scoping review.

Cadel L, Cimino S, Bradley-Ridout G, Hitzig S, Patel T, Ho C PLoS One. 2023; 18(5):e0285483.

PMID: 37200316 PMC: 10194931. DOI: 10.1371/journal.pone.0285483.

References

Topcuoglu M, Arsava E, Ay H . Antiplatelet resistance in stroke. Expert Rev Neurother. 2011; 11(2):251-63. PMC: 3086673. DOI: 10.1586/ern.10.203. View

Johnston S, Easton J, Farrant M, Barsan W, Conwit R, Elm J . Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018; 379(3):215-225. PMC: 6193486. DOI: 10.1056/NEJMoa1800410. View

Kl Chin P, Doogue M . Long-term prescribing of new oral anticoagulants. Aust Prescr. 2016; 39(6):200-204. PMC: 5155059. DOI: 10.18773/austprescr.2016.068. View

. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996; 348(9038):1329-39. DOI: 10.1016/s0140-6736(96)09457-3. View

Amarenco P, Bogousslavsky J, Callahan 3rd A, Goldstein L, Hennerici M, Rudolph A . High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006; 355(6):549-59. DOI: 10.1056/NEJMoa061894. View

Boan A, Egan B, Bachman D, Adams R, Feng W, Jauch E . Antihypertensive medication persistence 1-year post-stroke hospitalization. J Clin Hypertens (Greenwich). 2014; 16(12):869-74. PMC: 8031794. DOI: 10.1111/jch.12424. View

Kim J, Park M, Choi K, Cho K, Kim B, Han M . Different Antiplatelet Strategies in Patients With New Ischemic Stroke While Taking Aspirin. Stroke. 2015; 47(1):128-34. DOI: 10.1161/STROKEAHA.115.011595. View

. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360(9326):7-22. DOI: 10.1016/S0140-6736(02)09327-3. View

. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002; 324(7329):71-86. PMC: 64503. DOI: 10.1136/bmj.324.7329.71. View

10.

Hackam D, Spence J . Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack. Stroke. 2019; 50(3):773-778. DOI: 10.1161/STROKEAHA.118.023954. View

11.

Halkes P, van Gijn J, Kappelle L, Koudstaal P, Algra A . Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006; 367(9523):1665-73. DOI: 10.1016/S0140-6736(06)68734-5. View

12.

Wang Y, Pan Y, Zhao X, Li H, Wang D, Johnston S . Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes. Circulation. 2015; 132(1):40-6. DOI: 10.1161/CIRCULATIONAHA.114.014791. View

13.

Hart R, Sharma M, Mundl H, Kasner S, Bangdiwala S, Berkowitz S . Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med. 2018; 378(23):2191-2201. DOI: 10.1056/NEJMoa1802686. View

14.

Mukete B, Cassidy M, Ferdinand K, Le Jemtel T . Long-Term Anti-Hypertensive Therapy and Stroke Prevention: A Meta-Analysis. Am J Cardiovasc Drugs. 2015; 15(4):243-57. DOI: 10.1007/s40256-015-0129-0. View

15.

Ziff O, Banerjee G, Ambler G, Werring D . Statins and the risk of intracerebral haemorrhage in patients with stroke: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2018; 90(1):75-83. DOI: 10.1136/jnnp-2018-318483. View

16.

Sandercock P, Gibson L, Liu M . Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack. Cochrane Database Syst Rev. 2009; (2):CD000248. PMC: 7066483. DOI: 10.1002/14651858.CD000248.pub2. View

17.

Ettehad D, Emdin C, Kiran A, Anderson S, Callender T, Emberson J . Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016; 387(10022):957-967. DOI: 10.1016/S0140-6736(15)01225-8. View

18.

Grundy S, Stone N, Bailey A, Beam C, Birtcher K, Blumenthal R . 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018; 139(25):e1082-e1143. PMC: 7403606. DOI: 10.1161/CIR.0000000000000625. View

19.

Saxena R, Koudstaal P . Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. Cochrane Database Syst Rev. 2004; (4):CD000187. DOI: 10.1002/14651858.CD000187.pub2. View

20.

Barkat M, Hajibandeh S, Torella F, Antoniou G . Systematic Review and Meta-analysis of Dual Versus Single Antiplatelet Therapy in Carotid Interventions. Eur J Vasc Endovasc Surg. 2016; 53(1):53-67. DOI: 10.1016/j.ejvs.2016.10.011. View